Fever has been a preoccupation of clinicians since medicine's beginning. One might therefore expect that basic concepts relating to this physiological response would be well delineated and that such concepts would be widely known. In fact, only in the past several decades has the febrile response been subjected to scientific scrutiny. As a result of recent scientific investigation, modern concepts have evolved from a perception of fever as nothing more than a rise in core temperature to one in which fever is recognized as a complex physiological response characterized by a cytokinemediated rise in temperature, as well as by generation of acute-phase reactants and activation of a panoply of physiological, endocrinologic, and immunologic systems. The average clinician appears to have little more than a regrettably rudimentary knowledge of these modern concepts of fever. This symposium summary considers many such concepts that have immediate relevance to the practice of medicine.
The symposium began with a discussion of the thermal properties of the human body and then examined a question that Introduction -Philip A. Mackowiak, M.D.
has dogged clinicians since the earliest days of the profession: the diagnostic and prognostic significance of the fever pattern. Although fever is recognized clinically by its thermal characIt also considered the physiological mediators and metabolic teristics, it is in fact a complex physiological response to disproducts of the febrile response and how these might be manipease, characterized by a cytokine-mediated rise in core temperulated to benefit patients afflicted with a variety of disorders. ature, generation of acute-phase reactants, and activation of Finally, fever in HIV-infected patients -''the new frontier'' -numerous physiological, endocrinologic, and immunologic syswas examined as a prototypic clinical situation in which immetems. The limited data available (vide infra) suggest that the diate opportunities exist for direct clinical application of evolvaverage physician has at best a rudimentary knowledge of the ing basic concepts of the febrile response. response.
The symposium summarized here considered the current status of scientifically derived knowledge of the febrile response.
Thermal Properties of the Human Body -Philip A. This symposium, which was held in Baltimore in June 1995, Mackowiak, M.D. brought together a cadre of scientists/clinicians working in the Fever has been the subject of intense scrutiny since the field. It was designed to address concepts especially pertinent earliest days of clinical medicine. Therefore, one might reasonto clinical practice and to identify areas in which such concepts ably expect that basic concepts pertaining to the febrile reare likely to lead to significant advances in patient care in the sponse would have long since been elucidated and that such near future.
concepts would be firmly entrenched in the thinking of modernday clinicians. In fact, after over a millennium of clinical investigation, there is not even a generally accepted definition of fever. The enormity of our burden of ignorance in this regard their definition of ''normal body temperature'' (table 1) . Only 37ЊC (98.6ЊF) was not the overall mean temperature, the mean temperature of any of the time periods studied, the median 4% specified a particular body site (e.g., oral or rectal) for temperature measurements referred to in their definition.
temperature, or the single most frequently recorded temperature. Furthermore, it did not fall within the 99.9% confidence Temperatures selected to define fever (i.e., the lower end of the febrile range) varied between 36.9ЊC (98.5ЊF) and 40ЊC intervals for the sample mean (36.7 -36.8ЊC; 98.1 -98.2ЊF). Wunderlich regarded 38.0ЊC (100.4ЊF) as the upper limit of (104ЊF). Although 73% of those surveyed expressed a belief in the existence of a limit to the height of temperatures attained normal body temperature and, by extrapolation, any temperature greater than 38.0ЊC (100.4ЊF) as fever [6] . Modern medical during fever, there was not a consensus as to the specific temperature defining the upper limit of the febrile range. Finally, textbooks differ in their definition of the upper limit of normal oral temperature. Published values include 37.1ЊC (98.8ЊF) and infectious disease consultants surveyed did not appear to be more knowledgeable of these concepts than generalists or other 38ЊC (100.4ЊF) in textbooks of physiology [13, 14] The origin of these perceptions of body temperature is uncerand 37.4ЊC (99.4ЊF) in a recently published monograph on fever [16] . As noted above, a widely used medical dictionary tain, but in all likelihood it lies among the writings of Carl Wunderlich, who in 1868 published a book on clinical therdefines this same upper limit as 37ЊC (98.6ЊF) [1] . The source of the confusion over what constitutes the upper mometry that many regard, to this day, as the definitive work on the subject [3] . Unfortunately, several of Wunderlich's dictums limit of normal body temperature, I believe, is individual variability, which limits the application of mean values derived concerning body temperature, like the perceptions of modernday physicians, appear to be in error [4, 5] .
from population studies to individual subjects, and the fact that the maximum oral temperature (like the mean temperature) in According to Wunderlich, ''when the organism (man) is in a normal condition, the general temperature of the body maina population varies according to time of day and the site at which temperature measurements are taken. tains itself at the physiologic point: 37ЊC Å 98.6ЊFЉ [6] . Although several investigations since Wunderlich's have recorded
In the University of Maryland study population, 37.2ЊC (98.9ЊF) was the maximum oral temperature (i.e., the 99th mean temperatures of normal adult populations closer to 36.6ЊC (98.0ЊF) [7] , Wunderlich's intimation that 37ЊC (98.6ЊF) is the percentile) recorded at 6:00 A.M., whereas at 4:00 P.M. the maximum oral temperature observed reached 37.8Њ (99.9ЊF) most normal of temperatures persists to this day, not only in lay thinking but in medical writing as well [8 -12] .
(figure 2) [4] . Thus, these data suggest that when modern thermometers are used to monitor oral temperature in young or In 1992 investigators at the University of Maryland published a descriptive analysis of 700 baseline oral temperature middle-aged adults, fever is most appropriately defined as an early morning temperature of §37.2ЊC ( §99.0ЊF) or a temperaobservations for 148 healthy men and women, aged 18 -40 years [4] . In this population, oral temperatures exhibited a ture of §37.8ЊC ( §100ЊF) at anytime during the day. healthy persons according to time of day by 0.5ЊC Å 0.9ЊF'' [6] and that ''the lowest point is reached in the morning hours and mode of 36.7ЊC (98.0ЊF); 37ЊC (98.6ЊF) accounted for only 56 (8%) of the 700 oral temperature observations rebetween two and eight, and the highest in the afternoon between four and nine'' [17] . Modern authorities have generally concorded (figure 1).
Thus, these data suggest that 37ЊC (98.6ЊF) has no special curred with Wunderlich's observations on such matters [10, 15] . However, Täuber [11] has recently suggested that the amplitude significance vis á vis body temperature of healthy young adults, when such temperature is measured orally with modern therof diurnal variation might be as high as 1ЊC (1.8ЊF). The University of Maryland data are more consistent with Wunderlich's mometers. In the University of Maryland study population, [6] . In the University of Maryland survey, there was a trend toward higher temperatures among black subjects than white ers' oscillations were as narrow as 0.1ЊC (0.1ЊF).
According to Wunderlich, women have slightly higher norsubjects, with the differences approaching but not quite reaching statistical significance (Student's t-test: P Å .06; general mal temperatures than men and often have greater and more sudden changes in temperature [6] . In a study of 9 healthy linear model: P Å .05). It has been maintained for over a century that the elderly young adults (6 male and 3 female), Dinarello and Wolff [18] corroborated both observations. In the University of Maryland have lower body temperatures than do younger persons [6] . In a study reported in the Lancet in 1948, Howell [19] figure 3 ). Within this group fall fevers due to lobar and gram-negative pneumonia, the rickettsioses, typhoid are used as measures of body temperature but not if rectal readings are used.
fever, CNS disorders, tularemia, and falciparum (malignant tertian) malaria. Some authors believe that the first temperature reading obtained on admission to a hospital can be falsely elevated, beIntermittent (septic, quotidian, ''picket fence'') fever, with wide fluctuations, usually normal or low in the morning and cause stress, in the broadest sense, has the capacity to elevate body temperature [6, 16] . The University of Maryland study peaking between 4:00 and 8:00 P.M. This group includes fever due to localized pyogenic infections and bacterial endocardescribed above did not find evidence that the first temperature reading obtained after admission to a research study unit was ditis; chills and leukocytosis are usually present. Malaria (commonly with leukopenia) may present as quotidian (daily spike), less reliable than measurements obtained at later times [4] . Maryland investigators, however, could not be certain that tertian (spike every third day), or quartan (spike every fourth day) types. In acute brucellosis, fever is often intermittent, with stress levels at the time of admission to their unit were comparable to levels of stress experienced by patients at the time of sweating associated with leukopenia or a normal leukocyte count. A double quotidian pattern, with two daily spikes, occurs admission to a hospital.
As a result of work conducted earlier this century [22, 23] , sufficiently often to be helpful in diagnosis of salmonelloses, miliary tuberculosis, double malaria infections, and gonococcal it is widely believed that heart rate increases by 10 beats for each 1ЊF rise in body temperature. Data obtained in the Univerand meningococcal endocarditis. Saddle-back (biphasic) fever: several days of fever, a dissity of Maryland survey indicate that heart rate increases only 2.44 beats for each 1ЊF rise in temperature [4] . The difference tinct reduction in febrile levels for Ç1 day, and then several additional days of higher fever ( figure 4 ). This type of fever between the earlier and more recent investigations most likely reflects the fact that in the latter instance, subjects were afebrile pattern is typical of dengue and yellow fever, Colorado tick fever, relapsing fever, Rift Valley fever, influenza, and other and were examined while seated, whereas those examined in earlier investigations were mostly febrile and reclined on a viral infections such as poliomyelitis and lymphocytic choriomeningitis. couch for 20 minutes prior to examination.
The normal range of body temperature in children is not Intermittent hectic (Charcot's) fever: sporadic episodes of fever; periods of normal temperature and recurrence of fever. well delineated. Lorin [24] has written that the range is higher in children than in adults and that a decrease toward adult This is a frequent and reliable pattern in cholangitis, usually associated with cholelithiasis, jaundice, leukocytosis, and toxic levels begins at Ç1 year of age, continues through puberty, and stabilizes at 13 -14 years of age in girls and 17 -18 years signs; it may occur in patients without jaundice. scrutiny of fever patterns to a certain extent simulates gazing such differences are subtle and will rarely be detected unless time is taken to plot the fever curve on a continuous graph. at the Rockettes. In some respects, each is similar to the other, but careful evaluation reveals distinct differences not only in
In evaluation of a febrile illness, the mere contour of a daily fever pattern, coupled with chills, the presence or absence of shape but in topography, uniformity, and rhythm. However, CID a rash at a specified time, the nature of the rash, the blood ities to given cytokines with certainty. Such difficulties notwithstanding, several cytokines have been functionally grouped leukocyte count, and the manner in which the fever responds together on the basis of pyrogenic activity. In the future, this to treatment each have diagnostic relevance. For this reason, group of so-called pyrogenic cytokines will surely grow and one should not be satisfied simply with recognizing the exissome current members may be deleted. tence of a fever. The manner in which the fever begins and Currently recognized pyrogenic cytokines include IL-1 when it peaks (A.M. or P.M.) are helpful and, like those features (IL-1a and IL-1b), TNF-a, IL-6, and IFN (table 2) tor occupancy. After release, such cytokines can be found in Fortunately, molecular techniques now offer a more precise virtually all body fluids and exert local (autocrine/paracrine) means of categorizing and identifying cytokines.
as well as systemic (endocrine) effects.
Full understanding of cytokine physiology is complicated
The pivotal function of pyrogenic cytokines or ''endogenous by the fact that individual cytokines often influence expression pyrogens'' in mediating the febrile response has recently been of other cytokines and/or their receptors and may induce more reviewed by Kluger [36] , who proposed a series of five Koch's distal co-mediators of cytokine-induced bioactivities (e.g., postulate -like criteria for defining endogenous pyrogens. It is prostaglandins and platelet-activating factor). Therefore, it is interesting that of the four pyrogenic cytokines included in our discussion, only IL-6 satisfied all five criteria. According to not always possible to assign direct or intrinsic in vivo bioactiv- NOTE. C5a Å complement component C5a; CTL Å cytotoxic T-lymphocytes; GM-CSF Å granulocyte/macrophage colony stimulating factor; ICAM-1 Å intracellular adhesion molecule-1; IL-2R Å recombinant interleukin-2; LAK Å lymphokine-activated killer cell; LPS Å lipopolysaccharide (bacterial); MHC Å major histocompatibility complex; PAF Å platelet activating factor; PGE2 Å prostaglandin E2 ; PMA Å phorbal myristak acetate; staph TSST1 Å staphylococcal toxic shock syndrome toxin-1; TCR Å T-cell reactivity; TGFb Å transforming growth factor b; F Å enhanced expression; f Å inhibited expression. current concepts, exogenous and/or endogenous stimuli initiate proximity to the preoptic region of the anterior hypothalamus (figure 6), particularly in the area proximal to the organum the febrile response by being presented to specialized host cells that, in turn, respond by synthesizing and releasing specific vasculosum lamina terminalis [36] . Here, the cytokine-receptor interaction activates phospholipase A 2 , resulting in liberation amounts of various pyrogenic cytokines into the circulation (figure 6).
of plasma membrane arachidonic acid as substrate for the cyclooxgenase pathway. In a given host, a particular exogenous pyrogen (e.g., LPS or a virus) promotes release of its own characteristic pattern Some cytokines appear to increase cyclooxgenase expression directly, leading to liberation of an arachidonate metabolite, and concentration of cytokines. The pyrogenic cytokines themselves have the capacity to both upregulate and downregulate prostaglandin (PG) E 2 . This small lipid mediator easily diffuses across the blood-brain barrier, where it and perhaps other pyrotheir own expression, as well as that of other cytokines. Ultimately, each cytokine recognizes and binds to its own specific genic factors influence the responsiveness of the thermosensitive neurons that the thermoregulatory center comprises. Alreceptors, the most important of which -at least in terms of their thermoregulatory effects -are located on neurons in close though not discussed here, recent studies indicate that thermal / 9c33$$jy50 06-10-97 10:46:45 cida UC: CID information involved in the febrile response might also be investigations indicate that macrophage TNF-a expression is modulated at temperatures at least 2ЊC below the heat shock transmitted from the periphery to the thermoregulatory center via peripheral nerves.
response threshold [45, 46] . Thus, inhibition of TNF-a expression might occur as a component of the heat shock response, Several counterregulatory feedback mechanisms have been proposed for the attenuation of pyrogenic cytokine expression but fever might also modulate cytokine expression through a heat shock -independent process. and fever. While PGE 2 acts centrally to induce fever, it also appears to downregulate pyrogenic cytokine gene expression in the periphery. Corticosteroids have a similar inhibitory effect
The Acute-Phase Response -Robert S. Munford, M. D. on cytokine gene expression and phospholipase A 2 activity.
Naturally occurring cytokine receptor antagonists provide Many conditions that elicit fever also trigger production of acute phase proteins (APPs). Indeed, fever and APP synthesis negative feedback during the febrile response by competing with IL-1 and other pyrogenic cytokines at the receptor level.
(the acute-phase response) [51] are often considered cardinal components of the general host reaction to both trauma and Endogenous antipyretics such as arginine vasopressin and amelanocyte-stimulating hormone appear to provide a similar infection. There are, however, clinical conditions in which fever occurs in the absence of alterations in blood concentrations service during episodes of fever [37] .
Although work on pyrogenic cytokines over the past 2 deof APP, and others in which APP levels increase without concomitant fever, suggesting that the febrile and APP responses cades has provided a hypothetical model for the febrile response, our understanding of this process remains incomplete are independently regulated. APPs fall into two broad categories: positive and negative. and largely speculative. It is not known, for instance, whether circulating cytokines cross the blood brain barrier; if cytokines Numerous positive APPs are produced in increased amounts during the acute-phase response [52, 53] . Following major produced within the CNS are necessary for the febrile response; if local mediators other than PGE 2 are involved in fever; what trauma, plasma concentrations of such proteins may increase less than 4-fold (e.g., ceruloplasmin, haptoglobin) or as much determines the magnitude of expression of individual cytokines to various stimuli; or how the upper limit of the febrile range as 1,000-fold (e.g., C-reactive protein [CRP] and serum amyloid A). The rate of change in plasma concentration is also is set.
Although TNF-a and IL-1 play a pivotal role in initiating variable, with CRP and serum amyloid A levels increasing and decreasing more rapidly than, for example, levels of fibrinogen the febrile response [36] , they also continue to be expressed throughout episodes of fever [38] . A small but growing body or complement factors. Fewer negative APPs have been identified. Of these, albumin is the most prominent, although plasma of literature suggests that elevated temperatures near the upper end of the febrile range influence expression of such cytokines concentrations of transferrin and transthyretin (prealbumin) also decrease during the acute-phase response. in vitro and that these effects are highly dependent on experimental conditions [39 -46] (summarized in table 3) .
Most APPs are synthesized in the liver. Such synthesis is regulated by circulating cytokines and hormones, which induce The limited data currently available suggest that the in vivo effects of body temperature on cytokine expression are even specific transcription factors to activate (or inhibit) the promoter/enhancer domains of individual APP genes, thereby more complex [47 -50] . Although some authors have suggested that modulation of pyrogenic cytokines at febrile-range tempermodulating gene transcription [53, 54] . Synthesis of many APPs is also regulated by posttranscriptional mechanisms, such atures might involve the heat-shock response [41, 42] Similarly, IL-1Ra blocks production of CRP and serum amyloid A by LPS-stimulated human Hep 3B cells, while having
• IL-6 levels correlate with APP levels in various clinical states.
no effect on production of a1-protease inhibitor and increasing
• Intravenously administered IL-6 elicits APP production in vivo [58] .
production of fibrinogen [77] . Most clinical studies have mea-
• Monoclonal antibodies to IL-6 decrease APP production in response to sured CRP, the APP with the greatest dynamic range and yieldturpentine abscess in vivo [59, 60] and in humans with multiple myeloma [61], Castleman's disease [62] , and rheumatoid arthritis [63] .
ing the best quantitative assay results. Unfortunately, predicting is not possible.
/ 9c33$$jy50 06-10-97 10:46:45 cida UC: CID Defining specific roles for cytokines and related molecules in Both APP production and fever are found in most invasive bacterial diseases. An elevated plasma CRP concentration is human APP production has been difficult. Despite convincing evidence that IL-1Ra modulates APP production in mice with said to be highly suggestive of bacterial infection in children with illnesses of §12 hours' duration [85] . In children with turpentine abscesses [78] , for example, IL-1Ra has no apparent effect on the CRP response to low-dose endotoxin infusion in meningitis, a serum CRP level of ú20 mg/L strongly suggests a bacterial etiology [86] . Viral illnesses are generally associated volunteers [79] . Although there may be a simple explanation for this discrepancy (different inflammatory stimuli with difwith much smaller increases in CRP, although there is overlap with bacterial infections [87] . Extensive, acute thermal injury fering importance of IL-1 in APP production), such data raise serious questions about the relevance of results of animal studis another condition in which an elevated core temperature is closely associated with APP production, provided sufficient ies of APP to human diseases.
Fever and APP production are both components of the acutetime has elapsed for the APP response to occur [88, 89] . In other conditions, APP production may occur without fephase response, but can one occur without the other? In both experimental animals and humans, blocking elevation in core ver. For example, major surgery typically triggers vigorous APP production. CRP levels peak 2 -3 days after surgery and temperature during the febrile response with cyclooxygenase inhibitors has little or no impact on the normal APP response decline thereafter, usually approaching normal by postoperative day 7 [90 -92] . CRP elevations of lesser magnitude are frequent [80] . Elevation in core temperature per se is therefore not required for normal APP regulation. Is it sufficient? Does fever following myocardial infarction [93] . A recent report has also described slightly increased CRP levels in patients with unstainduce APP production? Intracerebral injection of low doses of TNF and IL-1 induces fever without increasing APP producble angina that progresses to myocardial infarction [94] . Many other conditions involving the musculoskeletal system also intion in mice, whereas higher doses of these cytokines elicit both fever and APP synthesis [71] .
duce APP production, even when fever is minimal or absent. These include chronic osteomyelitis, vertebral diskitis, prosvan Vugt and colleagues [81] have reported that hyperthermia and intracerebroventricular injection of PGE 2 elicit simithetic joint infections [95] , rheumatoid arthritis [96, 97] , spondyloarthropathies (psoriatic arthritis, ankylosing spondylitis), lar APP responses in rats. Both adrenalectomy and alpha-and beta-adrenergic blockade prevented the APP response but had polymyalgia rheumatica, and multiple myeloma. In patients with rheumatoid arthritis, CRP may be a useful no effect on PGE 2 -induced fever. Because adrenaline is a potent stimulus for IL-6 production in rats [82], these same marker for disease activity [96] . Although glucocorticoid therapy often reduces CRP levels directly, cyclooxygenase inhibiinvestigators have proposed that hyperthermia (or other stress), by raising circulating concentrations of adrenaline, tors (except for prinomide) appear to do so only when disease activity also diminishes [96, 98, 99] . elicits IL-6 production, which mediates augmented production of positive APPs.
In other clinical circumstances, fever may not be accompanied by APP production. Most interesting in this regard are a Although the role of adrenalin in APP regulation in humans is uncertain, these observations in rats suggest that APP producnumber of febrile viral and parasitic diseases in which there is little or no evidence of APP production. Trichinosis, for examtion should normally accompany the stress of fever or hyperthermia. As will be discussed below, exceptions to this generalple, is characteristically associated with a normal erythrocyte sedimentation rate. The explanation for the lack of enhanced ization provide some of the best available evidence that endogenous inhibitors of APP synthesis are clinically APP production during trichinosis is unknown. Helminthic infections typically induce a T-helper lymphocyte-2 immune reimportant.
Can any of the APPs induce fever? Recent reports would sponse, in which IL-4 and IL-10 predominate, but other factors are also involved in the response. In rats, gastrointestinal infecsuggest not. In fact, it has been shown that serum amyloid A inhibits fever induced by TNF-a or IL-1b in mice [83] and tions with Nippostrongylus brasiliensis and Trichinella spiralis fail to induce APP production, while systemic infection with that CRP and other APPs, by increasing the synthesis of IL1Ra in response to various agonists [84] , might also have an N. brasiliensis elicits brisk APP synthesis [100]. Marrow transplant recipients who develop fever during graftindirect antipyretic effect.
Febrile patients usually have increased levels of one or more versus-host disease typically do not have elevated CRP levels [101, 102] . Although the explanation for this finding has yet positive APPs, and patients with elevated levels of APPs usually have at least modest elevations in body temperature at some to be determined, one small study found that whereas such patients do not exhibit elevations in circulating IL-6 [102] , they time during the course of their illness. The distinction drawn here is that there are clinical situations in which the increase in usually have (often strikingly) elevated IgE levels, perhaps due to the activity of IL-4 [103] . As noted above, recombinant APP production (in most instances, the data are limited to CRP) and the degree of fever are less than might be anticipated from IL-4 induces minimal elevations of CRP levels in volunteers, while causing a marked increase in IL-1Ra levels [73] . the overall severity of the ongoing inflammatory response. Such situations provide further evidence that fever and APP producUnlike patients with other connective tissue diseases, patients with systemic lupus erythematosus often do not mount tion are independently regulated in humans.
/ 9c33$$jy50
06-10-97 10:46:45 cida UC: CID experimental studies in mice [106] . Whereas TNF-a is an im-
• In patients with rheumatoid arthritis, CRP levels often correlate directly portant proinflammatory cytokine in murine collagen IIwith disease activity and decrease in response to effective therapy [96] .
induced arthritis (a model for rheumatoid arthritis), it prevents
• Serial measurements of serum CRP levels may help predict or diagnose NZB/W F 1 mice from developing lupus. IL-10, by comparison, infectious complications in patients postoperatively [90 -92] .
• Monitoring CRP levels may be useful for following the resolution of opposes the inflammatory actions of TNFa in murine rheumapyelonephritis, meningitis, or pelvic infections (reviewed in [87] ). toid arthritis, while accelerating murine lupus. In keeping with randomization, double-blinding, or controls were used (because Patients with polymyositis/dermatomyositis, like those dethe technique of the randomized controlled trial had not yet scribed above, do not exhibit expected elevations in circulatbeen described for most of this period), the efficacy of fever ing CRP during exacerbations of their disease. A recent study therapy in syphilis is still unknown. [109] found that such patients have higher blood concentraFever therapy is experiencing a revival of sorts in the treattions of IL-1Ra and soluble TNF receptors (55 and 75 kD) ment of AIDS and chronic sequelae of Lyme disease. In addithan do patients with spondyloarthropathy, who have sigtion, there is mounting interest in the therapeutic application nificantly higher CRP levels. Serum CRP and IL-6 levels of several of the pyrogenic cytokines (see below). Although correlated positively in the patients with spondyloarthropapreliminary data suggest that such therapies have merit, carethy but not in patients with polymyositis/dermatomyositis. fully controlled, randomized, double-blind trials of such treatIn the latter patients, the circulating APP inhibitors (IL-1Ra, ments must be conducted if we are to avoid the kind of uncer-TNF receptors) thus seemed to dominate the agonists studied tainty that continues to plague modern-day assessment of (IL-6, TNF-a).
Wagner-Jauregg's highly acclaimed treatment for chronic CNS In conclusion, many factors appear to influence fever and syphilis. APP synthesis. Circulating concentrations of agonists and inhibitors (the mediator ''mix'') seem most important, yet the ways in which these molecules interact to regulate APP production and body temperature in vivo are poorly understood. NevTherapeutic Uses for Pyrogenic Cytokines -Ernest C. ertheless, the existing data leave little doubt that these two Borden, M.D. components of the host inflammatory response are regulated independently, a fact that makes CRP measurements useful in Of the major pyrogenic cytokines, the IFNs have enjoyed the widest application as therapeutic agents. IFNs typify lymseveral clinical situations (table 5) .
phokines and cytokines that modify the host response to microbial and neoplastic diseases. As human proteins, they differ Fever Therapy: Lessons for the Future -Paul D. Stolley, both chemically and biologically from most other therapeutic M.D., M.P.H.
molecules. IFNs were the first lymphokines or cytokines produced by There have been many attempts in the past to employ induced fever as a therapeutic agent. Indeed, the 1927 Nobel recombinant DNA technology and, indeed, the first such proteins used therapeutically (the first protein actually produced by Prize in Medicine was won by Julius Wagner-Jauregg for his work with fever therapy in the treatment of chronic syphilis recombinant DNA technology for therapeutic use was insulin). Substantial preclinical work initially focused on the antiviral infections of the CNS [110] .
The regimen pioneered by Wagner-Jauregg was severe, reactivity of IFNs; they are now used clinically in ú50 countries for the treatment of viral and neoplastic diseases [111, 112] . quiring several days of high fever produced by the injection / 9c33$$jy50 06-10-97 10:46:45 cida UC: CID IFNs are among the most potent of gene modulators, with ment with IFN-a 1 was Ç1ЊC lower than that following treatment with IFN-a 2 . the possible exception of glucocorticoids. Like the production of other cytokines, IFN production is tightly modulated. More In these studies, eight patients treated with IFN-a 1 required 1,300 mg of acetaminophen to control fever, vs. the 4,875 mg than 30 genes and their protein products are involved in the production of IFNs [113], including 2-5A synthetase and prorequired by those treated with IFN-a 2 . Despite these differences in pyrogenicity, the two IFNs were equivalent in their capacity tein kinase, as well as other lymphokines and cytokines. IFNs are not constitutively expressed; rather, they are produced only for augmenting 2-5A synthetase activity and potentiating NK cell cytotoxicity. in response to specific triggers such as double-stranded RNA or specific antigens.
In addition to modulating gene expression, IFNs and other cytokines stimulate glucocorticoid secretion. Patients given In the earliest clinical trials of IFNs [114], fever was recognized as a frequent side effect. Almost all patients develop fever IFN-b exhibit Ç2-fold increases in serum adrenocorticotropic hormone and cortisol levels 60 -120 minutes before the onset on the initial day of IFN treatment, and such fever likely represents one aspect of the broad cellular actions of IFNs. The initial of fever [124] . The anterior pituitary hormones, growth hormone and prolactin, are also stimulated Ç2-fold in a manner material, produced from human buffy coat blood donor units, was highly purified (Ç90%). However, not until the introduction similar to that observed after treatment with TNF [124] . Since the rise in glucocorticoids occurs prior to the onset of fever of IFNs produced by recombinant DNA technology, purified to homogeneity and proven to be endotoxin-free, was it clear that induced by IFNs and cytokines, it does not appear to be caused by the fever. Nevertheless, hormonal responses, like fever, difever is a side effect of the IFN molecule itself [115, 116] .
In a phase I clinical trial of IFN-b, 12 of 13 patients had a minish with repetitive IFN treatments. When recombinant IFNs were introduced into clinical trials fever on the initial day of treatment; by the fifth day of daily injections, only 3 of the 13 patients had a temperature ú37.5ЊC in 1981, it was not clear whether a therapeutic role would even be identified for such molecules. IFNs are now licensed for the [117] . This gradual diminution in pyrogenicity is one of the hallmarks of IFN therapy, a characteristic not shared by therapy treatment of numerous viral and neoplastic diseases and for multiple sclerosis. In addition to antiviral and pyrogenic activiwith other pyrogenic cytokines. For example, in a phase II clinical trial of IL-2 -another pyrogenic lymphokine licensed ties, IFNs also have antiproliferative, antiangiogenic, and immunomodulatory effects. They are currently among the top 10 for therapeutic use -26 of 28 patients treated with IL-2 developed a fever (temperature of §39ЊC) [118] , which did not drugs sold worldwide. Thus, 15 years after the introduction of IFNs into clinical resolve with repetitive dosing.
Temperature on the initial day of IFN therapy characteristimedicine, the question is not whether they are effective therapeutically but rather how they work. Their cellular effects are cally reaches a height of 38 -39ЊC orally, 5 -6 hours following IFN administration, and the fever persists for Ç2 hours. It is pleiotropic. It is not known, for example, whether papillomavirus clinical syndromes, which can be treated effectively with usually preceded by mild chills and malaise. However, in contrast to other lymphokines such as TNF [119] , the IFNs only IFNs, improve as a result of their antiviral effects or regress because of their immunologic, antiangiogenic, or antiproliferaoccasionally cause rigors.
The pyrogenicity of IFN is generally dose-related, as is modtive effects. Considerably more work must be done to elucidate such mechanisms, as well as those responsible for side effects ulation of gene expression [117, 120] . However, temperature elevations caused by IFN are characterized by substantial indisuch as fever, and to determine how to reduce the toxicity of such agents without compromising their therapeutic activity. vidual variability. It is interesting that production of lymphokines and cytokines such as IL-1b and colony stimulating factor-G is enhanced at temperatures at the upper end of the febrile Pyrogenic Cytokine Inhibitors: Clinical Applicationsrange, whereas TNF production is suppressed [121] .
Stanley A. Nasraway, M. D. Hyperthermia itself augments the effects of IFNs both in vitro and in vivo [122, 123] . Because IFN-induced fever reAn expanding array of scientific data suggest that pyrogenic cytokines such as TNF and IL-1 mediate at least some of the solves with repetitive dosing, it is not the most troublesome side effect of IFN therapy. Fatigue and anorexia are the primary pathophysiological derangements of septic shock [125] . As a result, there has been intense interest in the treatment of sedose-limiting side effects. The physiological mechanisms responsible for these adverse effects are poorly understood.
verely septic patients with agents capable of inhibiting pyrogenic cytokines. In contrast with other lymphokines and cytokines, the hematopoetic cytokines cause little elevation in temperature. Thus, One such agent, IL-1Ra, is released in quantities Ç100-fold greater than those of IL-1 itself following experimental each lymphokine and cytokine (including the various IFNs) exhibits its own characteristic pyrogenic response [116] . Two endotoxin challenge [126] and in even greater quantities (7,000 1) during human septic shock [127] . It is believed that this a IFNs produced by recombinant DNA technology exhibited different degrees of pyrogenicity on clinical testing at equivanaturally occurring receptor antagonist is part of a system of checks and balances within the host inflammatory response. lent doses. The mean maximum temperature following treat-/ 9c33$$jy50 06-10-97 10:46:45 cida UC: CID
Although initial efforts to test IL-1Ra in bacterial and fungal ment of sepsis on day 1, for example, is not likely to influence the development of multiple organ failure on day 30. As such, sepsis looked promising [128] , more rigorous study of ú1,400 patients with sepsis syndrome during phase IIIa and IIIb trials the landmark time point of 28 days mandated by the U.S. Food and Drug Administration is an insensitive, dichotomous failed to demonstrate a statistically significant improvement in survival rates with such treatment [129, 130] . Retrospective parameter of survival that can be skewed by nonseptic events that induce a low ''signal-to-noise'' ratio. Because not all subgroup analysis surprisingly revealed a paradoxical increase in IL-1 serum concentrations following IL-1Ra administration deaths (as an endpoint) are due directly to sepsis, heretofore many trials have been underpowered, with sample sizes insuf- [131] , underscoring the present limitations in our understanding of the cytokine network.
ficient to discriminate between therapeutic effect and mortality directly attributable to sepsis. Attempts to attenuate TNF activity in vivo have followed two paths: neutralization of endogenous TNF via monoclonal
Failure to focus on a narrow cohort of severely ill septic patients with potentially reversible physiological abnormaliantibodies and dilution of TNF activity via soluble receptors.
The latter concept has been tested in a phase II trial using ties, as opposed to an entire septic population in which a large reduction in mortality must be demonstrated in order to prove a p75 receptor/fusion construct. Unfortunately, mortality was greater among patients receiving high doses of soluble TNF benefit. The definition of ''sepsis syndrome'' has been too broad and has led to enrollment of patients with a wide specreceptor than among controls; as a result, further testing was abandoned (Immunex, data on file).
trum of severity of illness, with some patients not very ill and others in frank septic shock [129, 136 -138] . The heterogeneity It was subsequently demonstrated in a murine model of gram-negative sepsis that p75 receptor administration is associof enrolled patients, together with a mixture of comorbidities and conventional treatment approaches, confounds the interpreated with prolonged and tonic release of TNF, potentially aggravating the inflammatory response [132] . Human testing of tation of results because of uncontrolled variability and a low signal/noise ratio. another fusion construct, the p55 receptor, is ongoing (Hoffmann-LaRoche, data on file).
Failure to limit the analytical plan of human sepsis trials to a few, simple, clearly defined endpoints. Subgroup analysis NORASEPT I (North American Anti-TNF Sepsis Trial I), a trial of murine monoclonal antibody to TNF involving 971 should be preplanned and not, as in some earlier clinical trials, a post-hoc exercise [138] . patients with sepsis syndrome, found no overall improvement in survival rate among treated subjects [133] . However, in a Failure to recognize the limited applicability of animal models of sepsis. Animal models of sepsis, including direct endotoxin prospectively designed subanalysis of patients in shock, treatment was associated with an improved survival rate, especially infusion or intravenous bolus bacteremia, do not replicate human sepsis. Tolerance of bacteria and their products varies from species in the early period following antibody administration. NORA-SEPT II, the largest sepsis trial ever undertaken, is presently to species; results derived from animal models, therefore, may not necessarily apply to human sepsis. In certain cases, insufficient under way, with the intention of enrolling nearly 2,000 patients with septic shock. experimental evidence has been gathered to support hypothetical premises prior to launching human trials [136] [137] [138] [139] . A trial of MAK 195F, a murine IgG to TNF, in the treatment of patients with severe sepsis is also currently under considerFailure to perform an independent statistical analysis by authorities not associated with industry. This was evident ation. In this trial, severity of the septic condition is to be monitored by rapid serum assays for IL-6, since IL-6 concentraduring the publication by Centocor of the first phase III trial of HA-1A, a monoclonal antibody to endotoxin. Centocor pertions have previously been reported to correlate closely with mortality, multiple organ failure, and severity of illness during formed an in-house analysis and misrepresented the true results [139, 140] . sepsis [127, 134, 135] . Phase II testing has shown that for patients in whom IL-6 concentrations exceed 1,000 pg/mL, Careful clinical trials are important to critically evaluate new immunologic tools such as the pyrogenic cytokine inhibitors. administration of antibody to TNF reduces mortality by ú50% (Knoll Pharmaceutical, data on file).
The design of future trials should include the goal of minimizing patient heterogeneity, with an effort to enlist patients most Clinical trials involving inhibitors of pyrogenic cytokines, like those involving monoclonal antibodies to endotoxin, have likely to have reversible physiological abnormalities and, hence, most likely to benefit from therapeutic intervention. provided conflicting results. Careful review of such trials suggests that these discrepancies are due, in large part, to problems
The corollary to examining a narrow cohort population is the opportunity to limit harm by omitting non-target-population involved in statistical analysis and experimental design. Such problems include the following.
patients. Moreover, there should be an effort not to overinterpret unexpected results, as well as to limit the number of Failure to discriminate between attributable and nonattributable causes of death. Not all deaths of patients with sepsis prespecified endpoints and to establish a well-defined target P value that is corrected for test multiplicity. are due directly to sepsis; patients with sepsis die from comorbidities and from persistent multiple organ failure, which while Maximal inflammatory modulation may require combination immunotherapy in which ''cocktails'' of empirical antibiotics associated with sepsis may not be due directly to sepsis. Disseminated MAC infection is the most common cause of FUO in patients with advanced HIV infection, in large part involvement has occurred [160] . Non-Hodgkin's lymphoma ated as immunocompetent hosts. The following recommendations apply to patients with significant impairment of cell-medimay be seen in relatively early-stage HIV infection and is usually an aggressive, high-grade B-cell lymphoma with extenated immunity, as indicated by CD4 cell counts of õ200/mm 3 . Lactate dehydrogenase levels, while nonspecific, are usually sive visceral involvement and B-form symptoms, including fever [161, 162] . In some patients, the fever responds rapidly elevated in PCP, extrapulmonary tuberculosis, disseminated MAC infections, and lymphoma. Whereas serological tests for to naproxen challenge, which may serve as an important diagnostic clue [163] . CNS lymphoma is usually seen only in latetoxoplasmosis are useful in evaluating fever in patients with AIDS, the sensitivity of serological tests for coccidioidomycostage HIV disease and is infrequently associated with fever [161] . sis and histoplasmosis is low. Serum cryptococcal and histoplasmal antigen assays show sensitivities exceeding 85% Patients with HIV infections appear to be uniquely susceptible to adverse drug reactions, especially late in the course of [171, 172] . The PPD skin test has a sensitivity of 10% -70%, depending on the stage of HIV infection. their disease [164] . The frequency of fever among TMP-SMZ recipients is Ç20% [165] . Other drugs used for HIV-infected Anergy screening is no longer advocated for HIV-infected patients. With regard to scans, CT of the abdomen and chest patients that seem to be associated with high rates of adverse reactions (including fever) are dapsone, clindamycin, b-lactam is helpful diagnostically in 20% -50% of febrile patients with AIDS [173, 174] . Gallium scans are sensitive but not very antibiotics, phenytoin, carbamezepine, thalidomide, and pentamidine [165, 166] . Nucleoside analogs have rarely been specific and are most useful for patients with Kaposi's sarcoma of the lung, in whom gallium uptake is poor. Indium-labeled implicated as causes of fever [167] . Patients with febrile reactions (except for those due to pentamidine and AZT) almost leukocyte scintigraphy is more sensitive than gallium scintigraphy in AIDS patients with FUO [175] . always have an associated rash [164 -167] .
Injection drug use has been identified in 41% of recently Liver biopsy has a high diagnostic yield, especially when the serum alkaline phosphatase level is elevated. With alkaline reported cases of AIDS in the United States and is a risk factor having a differential diagnosis of fever independent of that phosphatase levels of 2.5 times the upper limit of normal, liver biopsy is reported to have a diagnostic yield as high as 75% associated with the HIV infection itself [168, 169] . A recent review of 121 febrile hospitalized injection-drug users showed [176] . Prior to performing such a biopsy, however, it is important to exclude diagnoses such as viral hepatitis, adverse 51% had bacteremia; Staphylococcus aureus accounted for 32 of the 61 cases (52%) and 15 of these patients had endocarditis drug reactions, and HIV-associated cholangiopathy. The most common diagnosis made via liver biopsy is mycobacterial in-(13% overall) [170] .
Guidelines for the evaluation of fever in patients with HIV fection. Bone marrow biopsies generally have lower diagnostic infections are based on signs, symptoms, and stage of disease. Patients with CD4 cell counts of ú500/mm 3 should be evaluyields than do liver biopsies [177] . The utility of a lumbar / 9c33$$jy50 06-10-97 10:46:45 cida UC: CID
